Byakangelicin

CAS No. 19573-01-4

Byakangelicin( —— )

Catalog No. M18189 CAS No. 19573-01-4

Byakangelicin is an antineoplastic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 95 In Stock
10MG 138 In Stock
25MG 221 In Stock
50MG 331 In Stock
100MG 492 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Byakangelicin
  • Note
    Research use only, not for human use.
  • Brief Description
    Byakangelicin is an antineoplastic agent.
  • Description
    Byakangelicin is an antineoplastic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19573-01-4
  • Formula Weight
    334.32
  • Molecular Formula
    C17H18O7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (299.11 mM)
  • SMILES
    CC(C)([C@@H](COc1c2c(c(c3c1oc(=O)cc3)OC)cco2)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang J, et al. Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes. Br J Pharmacol. 2011 Jan;162(2):441-51.
molnova catalog
related products
  • Elaiophylin

    Elaiophylin shows antiprotozoal activity against Plasmodium falciparum K1a and Trypanosoma brucei brucei GUTat 3.1 strains with IC50 of 0.36 μM and 0.45 μM, respectively.

  • Lepidiline C

    Lepidiline C is a novel imidazoles alkaloids extracted from the root of Lepidium meenii Walpers of the brassaceae family. It has shown cytotoxic activity against HL-60 cells (IC50:27.7 μM).

  • Ombrabulin hydrochlo...

    A novel combretastatin A-4 derivative that strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organ.